About
I am a medical oncologist who specializes in breast cancer and early phase clinical…
Activity
-
These were all our luggage when my wife and I first arrived in America for work coming from Australia ten years ago. We had no family, friends, or…
These were all our luggage when my wife and I first arrived in America for work coming from Australia ten years ago. We had no family, friends, or…
Liked by Ezra Rosen
-
The countdown is on! FOUR months until over 1,000 Fred's Team runners take on the TCS New York City Marathon on November 3! #FredsTeam #TCSNYCMarathon
The countdown is on! FOUR months until over 1,000 Fred's Team runners take on the TCS New York City Marathon on November 3! #FredsTeam #TCSNYCMarathon
Liked by Ezra Rosen
-
We did it! I am so pleased to announce that our consensus opinion on Leptomeningeal Metastasis has been published in Neuro-Oncology! This work was a…
We did it! I am so pleased to announce that our consensus opinion on Leptomeningeal Metastasis has been published in Neuro-Oncology! This work was a…
Liked by Ezra Rosen
Experience
More activity by Ezra
-
Pleased to share our recent work on the interplay of obesity and IO responses in endometrial cancer at Nicolás Gómez-Banoy, MD did a great job…
Pleased to share our recent work on the interplay of obesity and IO responses in endometrial cancer at Nicolás Gómez-Banoy, MD did a great job…
Liked by Ezra Rosen
-
So satisfying to work with a great team that delivers great medicines to offer promise to patients- the promise will soon become a reality …..that’s…
So satisfying to work with a great team that delivers great medicines to offer promise to patients- the promise will soon become a reality …..that’s…
Liked by Ezra Rosen
-
I could not be happier for Jorge Reis-Filho, the first William L. Gerald Awardee in industry. And I could not be happier to work with him in…
I could not be happier for Jorge Reis-Filho, the first William L. Gerald Awardee in industry. And I could not be happier to work with him in…
Liked by Ezra Rosen
-
Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology! - Antonio…
Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology! - Antonio…
Liked by Ezra Rosen
-
https://lnkd.in/eG_rPdFK
https://lnkd.in/eG_rPdFK
Liked by Ezra Rosen
-
When I first visited the White House one year ago, I was graciously hosted by Danielle Carnival, PhD and Catharine Young, Ph.D. at Cancer Moonshot…
When I first visited the White House one year ago, I was graciously hosted by Danielle Carnival, PhD and Catharine Young, Ph.D. at Cancer Moonshot…
Liked by Ezra Rosen
-
Today, the FDA approved the first CRISPR therapy to treat sickle cell disease, developed at Boston Children's Hospital. Drs. Stu Orkin, Vijay…
Today, the FDA approved the first CRISPR therapy to treat sickle cell disease, developed at Boston Children's Hospital. Drs. Stu Orkin, Vijay…
Liked by Ezra Rosen
-
Today we announced that the FDA has granted accelerated approval for one of our #oncology medicines in previously treated adult patients with…
Today we announced that the FDA has granted accelerated approval for one of our #oncology medicines in previously treated adult patients with…
Liked by Ezra Rosen
-
This is close to my heart: $RPTX announcing RP-3467, the best-in-class PolQ inhibitor to be dosed in patients in '24. The dedication and perseverance…
This is close to my heart: $RPTX announcing RP-3467, the best-in-class PolQ inhibitor to be dosed in patients in '24. The dedication and perseverance…
Liked by Ezra Rosen
-
Exciting news in the field of thoracic oncology! The latest National Comprehensive Cancer Network® (NCCN®) v5.2023 #lcsm guidelines have been…
Exciting news in the field of thoracic oncology! The latest National Comprehensive Cancer Network® (NCCN®) v5.2023 #lcsm guidelines have been…
Liked by Ezra Rosen
-
We’re pleased to welcome Dr. Craig Blinderman, MD, MA, FAAHPM as Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center…
We’re pleased to welcome Dr. Craig Blinderman, MD, MA, FAAHPM as Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center…
Liked by Ezra Rosen
-
Today we're celebrating the more than 1,000 employees who make up Memorial Sloan Kettering Cancer Center (MSK)'s Facilities team, including our…
Today we're celebrating the more than 1,000 employees who make up Memorial Sloan Kettering Cancer Center (MSK)'s Facilities team, including our…
Liked by Ezra Rosen
-
We’re thrilled to have recently welcomed Geoff Oxnard to our team as Vice President, Clinical Development, Global Head, Thoracic Cancer. We asked…
We’re thrilled to have recently welcomed Geoff Oxnard to our team as Vice President, Clinical Development, Global Head, Thoracic Cancer. We asked…
Liked by Ezra Rosen
-
Memorial Sloan Kettering Cancer Center breast oncologist and early drug development specialist Dr. Komal Jhaveri will speak about Imlunestrant with…
Memorial Sloan Kettering Cancer Center breast oncologist and early drug development specialist Dr. Komal Jhaveri will speak about Imlunestrant with…
Liked by Ezra Rosen
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Ezra Rosen in United States
-
Ezra Rosen
-
Ezra Rosen
O.C Kosher Mashgiach
-
Ezra Rosen
Student at Florida State University
-
ezra rosen
--
6 others named Ezra Rosen in United States are on LinkedIn
See others named Ezra Rosen